천식 및 만성폐색성폐질환 급여기준 합리화

: 생명을 위협하는 중증 천식 발작 상태, 급성 호흡부전의 위험으로 환기 보조 치료 요함.. 폐쇄폐병(obstructive pulmonary disease)

Respiratory acidosis and metabolic alkalosis : chronic lung disease and diuretics 5.. Mixed acute and chronic respiratory acidosis : chronic lung disease

– 후유증으로 불능(disability)를 동반하는 것 – 회복 불가능한 병리적 병변을 가지는 질병 – 재활에 특수한 훈련을 요하는 질병. – 장기간에 걸친 보호,

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the

- ‘만성질환 위험감소를 위한 섭취량( CDRR : Chronic Disease Risk Reduction intake) ’이란 건강한 인구집단에서 만성질환의 위험을 감소시킬 수 있는

Chronic kidney disease (partial update): Early identification and management of chronic kidney disease in adults in primary and secondary care (Clinical

1) Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. Yates, B.S., Jørgen Vestbo, M.D.,

GRIPHON Prostacyclin (PGI2) Receptor Agonist In Pulmonary Arterial Hypertension IPAH idiopathic pulmonary arterial hypertension MCTD mixed connective tissue